TTY Biopharm Company Limited (4105)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
77. 60
+0.4
+0.5181%
NT$
18.67B Market Cap
- P/E Ratio
14% Div Yield
501,286 Volume
- Eps
NT$ 77.2
Previous Close Want to track 4105 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TTY Biopharm Company Limited (4105) Statistics
Valuation metrics
Market Cap 18.67B
Enterprise value 17.26B
Trailing P/E (ttm) 11.82
Forward P/E -
PEG ratio 3.71
Price/Sales (ttm) 2.92
Price/Book (mrq) 3.03
Enterprise Value/Revenue 2.65
Enterprise Value/EBITDA 8.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 866.52K
Average volume (90 days) 883.76K
Price summary
52-Week low 71.6
52-Week high 87
Beta -
50-Day moving average 76.58
200-Day moving average 77.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4.5
Trailing annual dividend yield 0.0588%
5-Year annual dividend yield -
Payout ratio 0.64
Dividend Date 27 Apr 2026
Ex-Dividend Date 26 Mar 2026
Last split factor 1,067:1,000
Last split Date 13 Aug 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.25%
Operating margin 0.27%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.24%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 25.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 6.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 1.71%
Book value per share (mrq) 28.43
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
